159 related articles for article (PubMed ID: 37792507)
1. HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.
Kawasaki R; Oshige A; Yamana K; Hirano H; Nishimura K; Miura Y; Yorioka R; Sanada Y; Bando K; Tabata A; Yasuhara K; Miyazaki Y; Shinoda W; Nishimura T; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Nagasaki T; Ikeda A
Chemistry; 2023 Dec; 29(72):e202302486. PubMed ID: 37792507
[TBL] [Abstract][Full Text] [Related]
2. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
3. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
[No Abstract] [Full Text] [Related]
4. Tumor-targeting hyaluronic acid/fluorescent carborane complex for boron neutron capture therapy.
Yamana K; Kawasaki R; Sanada Y; Tabata A; Bando K; Yoshikawa K; Azuma H; Sakurai Y; Masunaga SI; Suzuki M; Sugikawa K; Nagasaki T; Ikeda A
Biochem Biophys Res Commun; 2021 Jun; 559():210-216. PubMed ID: 33957482
[TBL] [Abstract][Full Text] [Related]
5. Carborane-FAPI conjugate: A potential FAP-targeted boron agent with improved boron content.
Zhang J; Wu Y; Lu W; Xiao Y; Liu S; Yu J
Appl Radiat Isot; 2024 Jul; 209():111330. PubMed ID: 38657372
[TBL] [Abstract][Full Text] [Related]
6. Carborane bearing pullulan nanogel-boron oxide nanoparticle hybrid for boron neutron capture therapy.
Kawasaki R; Hirano H; Yamana K; Isozaki H; Kawamura S; Sanada Y; Bando K; Tabata A; Yoshikawa K; Azuma H; Takata T; Tanaka H; Sakurai Y; Suzuki M; Tarutani N; Katagiri K; Sawada SI; Sasaki Y; Akiyoshi K; Nagasaki T; Ikeda A
Nanomedicine; 2023 Apr; 49():102659. PubMed ID: 36822335
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy.
Yanagië H; Tomita T; Kobayashi H; Fujii Y; Nonaka Y; Saegusa Y; Hasumi K; Eriguchi M; Kobayashi T; Ono K
Br J Cancer; 1997; 75(5):660-5. PubMed ID: 9043021
[TBL] [Abstract][Full Text] [Related]
8. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
9. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
[TBL] [Abstract][Full Text] [Related]
10. Liposome formulations of o-carborane for the boron neutron capture therapy of cancer.
Olusanya TOB; Calabrese G; Fatouros DG; Tsibouklis J; Smith JR
Biophys Chem; 2019 Apr; 247():25-33. PubMed ID: 30797076
[TBL] [Abstract][Full Text] [Related]
11. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
[TBL] [Abstract][Full Text] [Related]
12. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
13. Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy.
Lai CH; Lin YC; Chou FI; Liang CF; Lin EW; Chuang YJ; Lin CC
Chem Commun (Camb); 2012 Jan; 48(4):612-4. PubMed ID: 22114760
[TBL] [Abstract][Full Text] [Related]
14. Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry.
Flieger S; Takagaki M; Kondo N; Lutz MR; Gupta Y; Ueda H; Sakurai Y; Moran G; Kempaiah P; Hosmane N; Suzuki M; Becker DP
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108137
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a carborane-containing cholesterol derivative and evaluation as a potential dual agent for MRI/BNCT applications.
Alberti D; Toppino A; Geninatti Crich S; Meraldi C; Prandi C; Protti N; Bortolussi S; Altieri S; Aime S; Deagostino A
Org Biomol Chem; 2014 Apr; 12(15):2457-67. PubMed ID: 24604345
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
Wang S; Blaha C; Santos R; Huynh T; Hayes TR; Beckford-Vera DR; Blecha JE; Hong AS; Fogarty M; Hope TA; Raleigh DR; Wilson DM; Evans MJ; VanBrocklin HF; Ozawa T; Flavell RR
Mol Pharm; 2019 Sep; 16(9):3831-3841. PubMed ID: 31381351
[TBL] [Abstract][Full Text] [Related]
17. Fructose-functionalized polymers to enhance therapeutic potential of p-boronophenylalanine for neutron capture therapy.
Nomoto T; Yao Y; Inoue Y; Suzuki M; Kanamori K; Takemoto H; Matsui M; Tomoda K; Nishiyama N
J Control Release; 2021 Apr; 332():184-193. PubMed ID: 33636247
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.
Kueffer PJ; Maitz CA; Khan AA; Schuster SA; Shlyakhtina NI; Jalisatgi SS; Brockman JD; Nigg DW; Hawthorne MF
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6512-7. PubMed ID: 23536304
[TBL] [Abstract][Full Text] [Related]
19. Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy.
Matović J; Bahrami K; Stockmann P; Sokka IK; Khng YC; Sarparanta M; Hey-Hawkins E; Rautio J; Ekholm FS
Mol Pharm; 2023 Jun; 20(6):3127-3139. PubMed ID: 37134022
[TBL] [Abstract][Full Text] [Related]
20. One step synthesis of
Kuthala N; Shanmugam M; Yao CL; Chiang CS; Hwang KC
Biomaterials; 2022 Nov; 290():121861. PubMed ID: 36302304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
